Titre:
  • Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.
Auteur:Chang, Chewei Anderson; Jen, Jayu; Jiang, Shaowen; Sayad, Azin; Mer, Arvind Singh; Brown, Kevin R; Nixon, Allison M L; Dhabaria, Avantika; Tang, Kwan Ho; Venet, David; Sotiriou, Christos; Deng, Jiehui; Wong, Kwok Kin; Adams, Sylvia; Meyn, Peter; Heguy, Adriana; Skok, Jane Amanda; Tsirigos, Aristotelis; Ueberheide, Beatrix; Moffat, Jason; Singh, Abhyudai; Haibe-Kains, Benjamin; Khodadadi-Jamayran, Alireza; Neel, Benjamin G
Informations sur la publication:Cancer Discovery, 12, 4, page (1022-1045)
Statut de publication:Publié, 2022-04-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Breast Neoplasms -- drug therapy -- genetics -- pathology
Cell Line, Tumor
Drug Resistance, Neoplasm
Female
Humans
Phosphatidylinositol 3-Kinases -- metabolism
Receptor, ErbB-2 -- genetics -- metabolism
Signal Transduction
Langue:Anglais
Identificateurs:urn:issn:2159-8274
info:doi/10.1158/2159-8290.CD-20-1265
info:pii/2159-8290.CD-20-1265
info:scp/85128161283
info:pmid/34911733
PMC8983469